Head to Head Review: RadNet (NASDAQ:RDNT) versus Privia Health Group (NASDAQ:PRVA)

Privia Health Group (NASDAQ:PRVA – Get Free Report) and RadNet (NASDAQ:RDNT – Get Free Report) are both mid-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, risk, profitability, institutional ownership, earnings and dividends.

Profitability

This table compares Privia Health Group and RadNet’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Privia Health Group 1.43% 4.20% 2.38%
RadNet -0.94% 3.14% 1.08%

Analyst Recommendations

This is a summary of recent recommendations for Privia Health Group and RadNet, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Privia Health Group 0 3 7 0 2.70
RadNet 1 1 6 1 2.78

Privia Health Group currently has a consensus price target of $31.30, indicating a potential upside of 24.95%. RadNet has a consensus price target of $89.67, indicating a potential upside of 28.63%. Given RadNet’s stronger consensus rating and higher probable upside, analysts clearly believe RadNet is more favorable than Privia Health Group.

Insider and Institutional Ownership

94.5% of Privia Health Group shares are owned by institutional investors. Comparatively, 77.9% of RadNet shares are owned by institutional investors. 5.7% of Privia Health Group shares are owned by company insiders. Comparatively, 5.1% of RadNet shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Valuation and Earnings

This table compares Privia Health Group and RadNet”s revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Privia Health Group $2.43 billion 1.31 $22.92 million $0.26 96.35
RadNet $2.04 billion 2.69 -$18.65 million ($0.29) -240.38

Privia Health Group has higher revenue and earnings than RadNet. RadNet is trading at a lower price-to-earnings ratio than Privia Health Group, indicating that it is currently the more affordable of the two stocks.

Risk & Volatility

Privia Health Group has a beta of 0.76, meaning that its stock price is 24% less volatile than the S&P 500. Comparatively, RadNet has a beta of 1.42, meaning that its stock price is 42% more volatile than the S&P 500.

Summary

Privia Health Group beats RadNet on 10 of the 15 factors compared between the two stocks.

About Privia Health Group

(Get Free Report)

Privia Health Group, Inc. is a physician enablement company that partners with independent medical groups, health systems and other providers. Its technology-enabled platform is designed to help physicians manage their practices and deliver coordinated care, while retaining their clinical independence. The company provides practice management, technology, care coordination and population health services. It also helps providers participate in value-based care arrangements, which tie payments more closely to the quality and efficiency of care.

About RadNet

(Get Free Report)

RadNet, Inc. operates outpatient diagnostic imaging centers in the United States. Its centers provide services including magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), mammography, ultrasound, X-ray and nuclear medicine imaging. The company serves patients, physicians and healthcare organizations, with operations across several states, including California, Delaware, Florida, Maryland, New Jersey and New York. Its imaging centers offer diagnostic services for a range of medical needs, from routine screening to specialized examinations.

Receive News & Ratings for Privia Health Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Privia Health Group and related companies with MarketBeat.com's FREE daily email newsletter.